FACTS: Frequency Therapeutics’s most recent trial data on FX-322 demonstrates reversal of hearing loss is very real and might be hitting markets in the near…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.